Rob Zombie Crushes Billboard Charts: #1 in Top Album Sales, #9 in Top 200

S. Bollmann, CC BY-SA 3.0 , via Wikimedia Commons
Published on:

Last week saw monster rock kingpin Rob Zombie release his latest full-length album The Lunar Injection Kool Aid Conspiracy Theory to critical acclaim and plenty of spooky booty-shaking. Now, it looks as though the record has not only done well for Zombie, it’s created some impressive firsts for him, with Lunar Injection landing multiple spots of honor on the Billboard charts.

According to Billboard, Zombie’s new album sees the shock rocker landing his first #1 on the Top Album Sales chart. The record sold 26,000 unites, with physical album sales making up 20,000 of that figure (13,200 of those sales were CDs, 6,500 were vinyl, and 300 were cassette). The remaining 6,000 were digital albums. It’s worth noting that the Top Album Sales chart relates solely to the traditional sale of records and doesn’t account for streaming, which makes sense given that Zombie’s fans love art and have a penchant for old-school nostalgia.

It’s also worth noting that this is the first #1 Top Album Sales position for Nuclear Blast. The metal label’s closest up until this point was for Slayer’s Repentless.

The album also landed #1 spots in the Current Rock Albums and Current Hard Music Albums categories.

Meanwhile, on Billboard’s infamous Top 200, Zombie still managed to crack the Top 10, coming in at #9. This puts The Lunar Injection Kool Aid Conspiracy among artists including Pop Smoke, Morgan Wallen, and The Weekend — not necessarily the crew one would expect Zombie to roll with, though we get the feeling that if they saw this chart they’d say, “Oh, fuck yeah, Rob Zombie!” Because that’s what heroes do.


View this post on Instagram


A post shared by RobZombieofficial (@robzombieofficial)

Congrats to Rob on his chart-topping success. Rob Zombie’s The Lunar Injection Kool Aid conspiracy is out now on Nuclear Blast Records. Listen to the album’s massive closing track “Crow Killer Blues” below:


Words by Chris Krovatin